Condition

Nasopharangeal Cancer clinical trials and research

• 6Clinical trials
• 2Countries

Newest Nasopharangeal Cancer clinical trials

All recruiting trials (6)

• Chlorhexidine spray to prevent radiation skin damage during nasopharyngeal cancer treatment

  This trial will test whether applying a 2% chlorhexidine spray during chemoradiotherapy reduces skin irritation and improves quality of life for people with stage II–III nasopharyngeal cancer.

  Recruiting Phase 3 Jiangxi Provincial Cancer Hospital · Nanchang, Jiangxi · NCT07559877

• Immunotherapy versus capecitabine maintenance after chemo‑chemoradiotherapy for high‑risk nasopharyngeal cancer

  This test compares PD‑1 immunotherapy maintenance to capecitabine maintenance after chemo‑chemoradiotherapy for people with high‑risk locally advanced nasopharyngeal cancer who responded to initial chemo‑immunotherapy.

  Recruiting Phase 2 Sun Yat-sen University · Guangzhou, Guangdong · NCT07392320

• PD-1 inhibitor plus chemotherapy followed by immediate versus selective re-irradiation for locally advanced recurrent nasopharyngeal carcinoma

  This phase II trial tests whether immediate or selective re-irradiation after a good response to PD-1 inhibitor plus gemcitabine-cisplatin helps people with locally advanced recurrent nasopharyngeal carcinoma live longer with acceptable side effects.

  Recruiting Phase 2 Sun Yat-sen University · Guangzhou, Guangdong · NCT07332247

• Low-dose radiotherapy with toripalimab and chemotherapy for recurrent or metastatic nasopharyngeal cancer

  This will test whether adding low-dose radiotherapy to toripalimab plus gemcitabine‑cisplatin helps people with recurrent or metastatic nasopharyngeal cancer respond better while staying safe.

  Recruiting at 2 sites Phase 2 Sun Yat-sen University · Guangzhou, Guangdong and 1 other locations · NCT07325539

• PD-1 immunotherapy with chemotherapy followed by immediate or delayed local radiation for newly metastatic nasopharyngeal cancer

  This trial tests whether waiting to give local radiotherapy (only if needed) after PD‑1 immunotherapy plus gemcitabine‑cisplatin works as well and causes less toxicity than giving radiotherapy right away for people with newly diagnosed metastatic nasopharyngeal cancer who respond to initial treatment.

  Recruiting at 3 sites Phase 3 Sun Yat-sen University · Guangzhou, Guangdong and 4 other locations · NCT07235319

• Testing trastuzumab deruxtecan (T‑DxD) for HER2‑positive advanced solid tumors

  This will test whether trastuzumab deruxtecan (T‑DxD) helps adults in the US with HER2‑positive (IHC 3+) locally advanced, unresectable, or metastatic solid tumors who have had prior systemic treatment and have no satisfactory alternative options.

  Recruiting at 18 sites AstraZeneca · Birmingham, Alabama and 17 other locations · NCT07124000

Related topics

Quick answers

How many Nasopharangeal Cancer clinical trials are recruiting right now?

6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 2 countries. The most sites are in China (5 trials), United States (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 3, Phase 3: 2. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →